A Study to Evaluate Safety, and Efficacy of SUVN-G3031 in Patients With Narcolepsy With and Without Cataplexy
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study is of an investigational drug called SUVN-G3031 as a possible treatment for
narcolepsy with cataplexy or narcolepsy without cataplexy. The main purpose of this study is
to learn how well the study drug works and how safe the study drug is compared to placebo.